Targeted or Chemotherapy Combined With Immunotherapy Versus Chemotherapy for PD-1 Inhibitor Refractory R/M NPC
Clinical trial NCT05549466 · UNKNOWN
Trial details
- NCT number
- NCT05549466
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-08
- Primary completion
- 2023-09-20
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.